Coya Therapeutics, Inc. (COYA)

NCM – Real Time Price. Currency in USD

4.29

+0.11 (2.63%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-27K

Gross Profit

-27K

Operating expenses (excl. COGS)

-28M

-21M

-13M

-9M

Operating Income

-20M

-17M

-7M

-9M

Non-operating income, total

-957K

96K

-3M

Pretax income

-21M

-16M

-7M

-12M

Equity in earnings

Taxes

-3K

720K

-724K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-21M

-15M

-8M

-12M

Coya Therapeutics, Inc. (COYA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Coya Therapeutics, Inc. (COYA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Coya Therapeutics, Inc. (COYA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Coya Therapeutics, Inc. (COYA)

Income Statement (Annual)

Income Statement (Annual)